Reason for request
Re-assessment of Actual Benefit of proprietary medicinal products based on dihydroergotamine, in accordance with Article R 163-21 of the social security code and renewal of inclusion on the list of medicinal products refundable by National Health Insurance.
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
CHYkmxmUccrVncSg
